Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

199
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
199
Drug Therapy01:28

Drug Therapy

226
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
226
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

200
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
200
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

201
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
201
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

1.1K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.1K
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

146
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
146

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving medicines use in people with polypharmacy in primary care: a synopsis from the IMPPP cluster-RCT with pilot-feasibility study.

Health and social care delivery research·2026
Same author

Sustainable implementation of practice-based research networks in primary care: a qualitative process evaluation of the Bavarian Research Practice Network (BayFoNet).

BMC primary care·2026
Same author

Development of phenotype algorithms for the detection of adverse events in electronic health record data: a multicentre study.

BMJ open·2026
Same author

Upward Air Temperature Shifts and Acute Cardiovascular Events in Individuals with Atherosclerotic Cardiovascular Disease: A Time-Stratified Case-Crossover Study.

The Lancet regional health. Europe·2026
Same author

Associations between COVID-19 Severity, Cognitive Impairment, and Quality of Life in Individuals in Need of Care: Results from the Multicentre Registry Study BaCoM.

Dementia and geriatric cognitive disorders extra·2026
Same author

Feasibility of a conversation-based brief intervention in general practice to reduce post-traumatic symptoms after intensive care treatment-A qualitative analysis of the PICTURE study.

PLOS mental health·2026

Related Experiment Video

Updated: Jan 6, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.4K

Addressing the Challenge of Polypharmacy.

Alpana Mair1, Martin Wilson2, Tobias Dreischulte3,4

  • 1Effective Prescribing and Therapeutics, Scottish Government, Edinburgh EH1 3DG, United Kingdom;

Annual Review of Pharmacology and Toxicology
|October 8, 2019
PubMed
Summary

Polypharmacy, the use of multiple medications, poses risks outweighing benefits in aging populations. Guidance and system changes are crucial for realistic drug treatment goals and improved patient outcomes.

Keywords:
adherenceappropriate polypharmacydeprescribingeffectivenessmedication reviewpatient-centeredsafety

More Related Videos

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

10.1K
Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

5.3K

Related Experiment Videos

Last Updated: Jan 6, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.4K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

10.1K
Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

5.3K

Area of Science:

  • Gerontology
  • Clinical Pharmacy
  • Public Health

Background:

  • Polypharmacy, the concurrent use of multiple medications, is a growing global challenge.
  • Aging populations and multimorbidity contribute to increased polypharmacy.
  • Problematic polypharmacy occurs when risks (drug interactions, disease interactions, monitoring burden) outweigh benefits.

Purpose of the Study:

  • To address the challenges posed by polypharmacy.
  • To provide guidance for realistic drug treatment goals.
  • To outline system changes needed for polypharmacy management.

Main Methods:

  • Review of lessons from two programs addressing polypharmacy challenges.
  • Analysis of the Scottish polypharmacy guidance on realistic prescribing.
  • Examination of the European Union SIMPATHY project.

Main Results:

  • Polypharmacy has significant economic impacts (service demand, hospitalization).
  • It detrimentally affects patients' quality of life.
  • Up to 50% of patients on four or more medications may not adhere to prescriptions, leading to therapeutic failure.

Conclusions:

  • Guidance is needed to support patients and clinicians in setting realistic drug treatment goals.
  • System-level changes are necessary for effective polypharmacy implementation.
  • Learning from initiatives like the Scottish guidance and SIMPATHY project can inform future strategies.